You have 9 free searches left this month | for more free features.

non-del(5q) MDS

Showing 1 - 25 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

MDS Trial in United States (Lenalidomide, Luspatercept)

Recruiting
  • Myelodysplastic Syndromes
  • Miami, Florida
  • +5 more
Sep 28, 2022

MDS, Myelodysplastic Anemia, Myelodysplastic Syndrome With Isolated Del(5Q) Trial (description of MDS pzatient cohort)

Recruiting
  • Myelodysplastic Syndromes
  • +5 more
  • description of MDS pzatient cohort
  • Brest, France
    Chu Brest
Oct 27, 2022

Myelodysplastic Syndrome Trial in Worldwide (Lenalidomide)

Completed
  • Myelodysplastic Syndrome
  • Centre City, New Jersey
  • +148 more
Aug 18, 2022

MDS, Del(5Q), Anemia Trial in Italy (Luspatercept Injection [Reblozyl])

Recruiting
  • Myelodysplastic Syndromes
  • +3 more
  • Luspatercept Injection [Reblozyl]
  • Alessandria, Italy
  • +22 more
Jun 20, 2023

Myelodysplastic Syndrome, MDS Trial in Gainesville, Tampa (Prednisone, Lenalidomide)

Completed
  • Myelodysplastic Syndrome
  • MDS
  • Gainesville, Florida
  • +1 more
Dec 10, 2019

Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, Adult Acute Myeloid Leukemia With Del(5q), Adult Acute Myeloid

Active, not recruiting
  • Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities
  • +9 more
  • Sewell, New Jersey
  • +4 more
Dec 13, 2022

Myelodysplastic Syndrome Trial in New York (Revlimid (Lenalidomide))

Active, not recruiting
  • Myelodysplastic Syndrome
  • Revlimid (Lenalidomide)
  • New York, New York
    Columbia University Medical Center
Jan 12, 2022

Analyze Occurrence of Transformation From Myelodysplastic

Completed
  • Myelodysplastic Syndromes
  • Leukemia, Myeloid, Acute
    • Kobe, Hyogo, Japan
      Shinko Hospital
    Jun 13, 2022

    Tumors, Solid Tumor, Adult, Non-Hodgkin Lymphoma Trial in Worldwide (JNJ-64619178)

    Active, not recruiting
    • Neoplasms
    • +3 more
    • Sarasota, Florida
    • +17 more
    Jan 27, 2023

    Haploinsufficiency of RBM22 and SLU7 Genes in Del(5q)

    Recruiting
    • Myelodysplastic Syndromes
    • +2 more
    • somatic cytogenetic and genetic characterization
    • Brest, France
    • +2 more
    Jan 6, 2021

    Adult Acute Megakaryoblastic Leukemia (M7), Adult Acute Minimally Differentiated Myeloid Leukemia (M0), Adult Acute Monoblastic

    Completed
    • Adult Acute Megakaryoblastic Leukemia (M7)
    • +16 more
    • standard follow-up care
    • +2 more
    • Seattle, Washington
      Fred Hutchinson Cancer Research Center/University of Washington
    Jul 29, 2020

    MDS, MDS/MPN Crossover Syndromes Trial in Cleveland (5-azacytidine, Decitabine)

    Recruiting
    • Myelodysplastic Syndromes
    • MDS/MPN Crossover Syndromes
    • Cleveland, Ohio
      Cleveland Medical Center, University Hospitals Seidman Cancer Ce
    Aug 10, 2022

    Adult Acute Lymphoblastic Leukemia in Remission, Adult Acute Myeloid Leukemia in Remission, Adult Acute Myeloid Leukemia With

    Active, not recruiting
    • Adult Acute Lymphoblastic Leukemia in Remission
    • +14 more
    • radiation therapy
    • +8 more
    • Columbus, Ohio
      Arthur G. James Cancer Hospital and Solove Research Institute at
    Oct 7, 2022

    REVLIMID® Treatment of IPSS Low- or Intermediate-1-risk

    Recruiting
    • Myelodysplastic Syndromes
    • +2 more
    • Anyang, Korea, Republic of
    • +12 more
    Apr 6, 2021

    MDS Trial in France (EPREX)

    Recruiting
    • Myelodysplastic Syndromes
    • Amiens, France
    • +38 more
    Dec 1, 2020

    MDS Trial in Beijing (Lenalidomide, Azacitidine)

    Not yet recruiting
    • Myelodysplastic Syndromes
    • Beijing, China
      Peking union medical college hospital
    Aug 16, 2023

    Adult Acute Megakaryoblastic Leukemia (M7), Adult Acute Monoblastic Leukemia (M5a), Adult Acute Monocytic Leukemia (M5b) Trial

    Completed
    • Adult Acute Megakaryoblastic Leukemia (M7)
    • +13 more
    • Philadelphia, Pennsylvania
      Thomas Jefferson University
    Feb 2, 2023

    Adult Acute Megakaryoblastic Leukemia (M7), Adult Acute Minimally Differentiated Myeloid Leukemia (M0), Adult Acute Monoblastic

    Completed
    • Adult Acute Megakaryoblastic Leukemia (M7)
    • +15 more
    • trebananib
    • +3 more
    • Buffalo, New York
    • +1 more
    Sep 8, 2022

    Adult Acute Basophilic Leukemia, Adult Acute Eosinophilic Leukemia, Adult Acute Megakaryoblastic Leukemia (M7) Trial in Atlanta,

    Terminated
    • Adult Acute Basophilic Leukemia
    • +16 more
    • eltrombopag olamine
    • standard follow-up care
    • Atlanta, Georgia
    • +1 more
    Jul 20, 2022

    Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, Adult Acute Myeloid Leukemia With Del(5q), Adult Acute Myeloid

    Terminated
    • Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities
    • +8 more
    • Duarte, California
      City of Hope Medical Center
    Mar 28, 2022

    Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, Adult Acute Myeloid Leukemia With Del(5q), Adult Acute Myeloid

    Recruiting
    • Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities
    • +9 more
    • Duarte, California
      City of Hope Medical Center
    May 19, 2022

    Myelodysplastic Syndrome Trial in France, Germany, Spain (Lenalidomide, Placebo)

    Active, not recruiting
    • Myelodysplastic Syndrome
    • Strasbourg, Bajo Rin, France
    • +24 more
    Nov 22, 2021

    MDS Trial (Imetelstat)

    Available
    • Myelodysplastic Syndromes
    • (no location specified)
    Jun 30, 2023

    Accelerated Phase Chronic Myelogenous Leukemia, Adult Acute Lymphoblastic Leukemia in Remission, Adult Acute Myeloid Leukemia in

    Completed
    • Accelerated Phase Chronic Myelogenous Leukemia
    • +23 more
    • Denver, Colorado
    • +2 more
    Jun 17, 2021

    Acute Myeloid Leukemia With Multilineage Dysplasia Following Myelodysplastic Syndrome, Adult Acute Basophilic Leukemia, Adult

    Active, not recruiting
    • Acute Myeloid Leukemia With Multilineage Dysplasia Following Myelodysplastic Syndrome
    • +18 more
    • eltrombopag olamine
    • Cleveland, Ohio
      Case Comprehensive Cancer Center
    Nov 29, 2021